Terazosin Capsule
Product Images NDC 63187-620

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 63187-620). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-620-30 (Terazosin 4 mg)

Label for Terazosin 10 mg capsules, containing 30 capsules per bottle. Each capsule contains Terazosin Hydrochloride equivalent to 10 mg terazosin. The capsules have light green opaque cap and body printed with "TL 386" in black ink. Manufactured by Jubilant Cadista Pharmaceuticals Inc. and packaged by Proficient Rx LP.*

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

Chemical structure of Terazosin Hydrochloride, showing the molecular arrangement of atoms and functional groups typical of this active ingredient.*

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

Two graphs showing clinical data comparing Terazosin and placebo over three months. The left graph depicts mean change in total symptom score from baseline, showing a greater decrease for Terazosin versus placebo. The right graph shows mean increase in peak flow rate (mL/sec) from baseline, with Terazosin patients exhibiting a larger increase than placebo over the same period.*

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

A line graph showing mean change from baseline over a 30-month period. The y-axis represents mean change, while the x-axis shows months from 0 to 30. Data points are plotted with circles and stars to indicate significance at various intervals during the study duration.*

FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

A line graph showing the mean change from baseline in nL/sec over a 30-month period. The x-axis is labeled in months from 0 to 30, and the y-axis represents the mean change from baseline, ranging from 0 to 4.5. Data points are indicated with error bars, and several points are marked with asterisks, likely denoting statistical significance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.